The accelerated blood clearance (ABC) phenomenon, caused in large degree via in vivo anti-PEG
IgM production, is one of obstacles for development of PEGylated
liposome and
protein formulations, due to decreased efficiency and/or side effects such as
anaphylaxis upon repeat administrations. We have shown in murine ABC models that
splenectomy suppressed the level of anti-PEG
IgM production induced by PEGylated
liposomes, indicating that murine splenic B cells play an important role in its production. However,
splenectomy did not completely inhibit production of anti-PEG
IgM, suggesting that other cells may contribute to its production in the ABC phenomenon. In this study, we examined the contribution of hepatosplenic phagocytic cells to anti-PEG
IgM production and clearance of PEGylated
liposomes during the ABC phenomenon. Depletion of hepatosplenic phagocytic cells by pretreatment of mice with
clodronate-containing non-PEGylated
liposomes suppressed anti-PEG
IgM production to a considerable degree, without a change in the number of splenic B cells, and attenuated the enhanced clearance of second dose of PEGylated
liposomes. These results suggest that hepatosplenic phagocytic cells, in addition to splenic B cells, contribute to the production of anti-PEG
IgM and the ABC phenomenon against PEGylated
liposomes. The mechanism whereby splenic B cells interact with hepatosplenic phagocytic cells to produce anti-PEG
IgM, upon administration of an initial dose of PEGylated
liposomes remains to be elucidated.